Description
Active substance: Ruxolitinib
Therapeutic area: Oncology — Haematology (leukaemia, lymphoma, myeloma)
We can source this product for you through our international network of licensed partners. Send us a request and we will check availability, price and lead time.
Subject to availability. Prices and lead times on request.
